New Generics Need To Influence Medicare Rates More Quickly – OIG
Health and Human Services' Office of Inspector General is calling on the Centers for Medicare and Medicaid Services to more quickly adjust reimbursement rates for Medicare Part B drugs when low-priced generics enter the market
You may also be interested in...
CMS says the two-quarter lag in average sales price data for new generic drugs used for reimbursement under Medicare Part B encourages the transition from brand to generic products.
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.